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Abstract
Azidohomoalanine (Aha) is an unnatural amino acid containing an infrared active azido side
chain group which can, through frequency shifts of the azido stretch vibration, act as a probe
of local structure. To realize the potential of such structural probes for protein science, we
have developed a two-dimensional infrared spectrometer employing fast mechanical scanning and
intrinsic phasing of the resulting spectra, leading to a lower sensitivity limit of ∼100 µOD level
samples. Using this approach, we quantify the biomolecular recognition between a PDZ2 domain
and two Aha-mutated peptides. It is shown that this method can distinguish different binding
modes, and that the energetics of binding can be determined.
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Biomolecular recognition underlies enzymatic activity and signal transduction pathways
in effectively all cellular processes, where the energetics of molecular recognition in combina-
tion with local concentrations determine the likelihood of protein-protein or protein-ligand
binding, and therefore the probability of occurrence of different cellular processes. Know-
ing these energetics is necessary to understand both the native biochemistry of the cell,
and to identify, design, and characterize new drugs with which to control cellular function1.
Quantifying biomolecular recognition has commonly been the domain of isothermal titration
calorimetry (ITC), where the heat of binding between a protein and ligand is monitored as
a function of their relative molar ratio2. While not a direct measure of structural interac-
tions, through prior knowledge of the binding properties of the biomolecules of interest, it is
possible to recover the free energy, enthalpy, and entropy of a binding event2–4. Alternative
approaches to measuring protein-ligand interactions, often with greater structural specificity,
consist of nuclear magnetic resonance (NMR) spectroscopy (either from the point of view
of the protein5–8 or the ligand5,9), x-ray crystallography10 or scattering11,12, and mass spec-
trometry techniques13–16, among many others, each with their own strengths, weaknesses,
and applicable affinity regimes1.
Here, we propose the use of unnatural amino acids with infrared activity in combination
with two-dimensional infrared spectroscopy (2D IR) as a means of quantifying equilibrium
protein-protein or protein-ligand interactions. Various unnatural amino acids with infrared
active side chains have been developed17–21, which have proven to be sensitive reporters of
local structural changes (e.g. protein folding19 or dynamics22–24). In contrast with ther-
modynamic approaches, single point mutations to infrared-active unnatural amino acids al-
low for site-specific, and thus structural, information regarding biomolecular recognition25.
However, experimental limitations have to now hampered the general applicability of this
method. The molecular vibrations of nitrile- or azido-modified amino acids have central fre-
quencies in the range of 2100–2300 cm−1, a spectral region free of native protein vibrations,
but with significant H2O or D2O solvent response
26. Among the various IR active amino
acids, Azidohomoalanine (Aha) may be the most versatile, since it can be incorporated into
a protein at essentially any position using a Met auxotrophic expression strategy without the
need of an additional chemical modification after protein expression27. As a relatively strong
absorber with an extinction coefficient of ∼300 M−1 cm−125, the Aha signal is nevertheless
still miniscule compared to the solvent response due to the inability to concentrate most
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proteins beyond ∼1 mM. In contrast, the water extinction coefficients in this spectral region
are some two orders of magnitude smaller, but at a concentration of ∼56 M. The reliable
extraction of information pertaining strictly to the protein is thus a significant challenge,
particularly with linear infrared spectroscopy.
2D IR spectroscopy28, a vibrational analogue of 2D NMR spectroscopy, offers a compelling
solution to the signal amplitude mismatch described above. As a nonlinear spectroscopy,
2D IR signals scale quadratically with the extinction coefficient, in contrast with the linear
nature of FTIR. This acts to significantly enhance the infrared response of the unnatural
amino acid vibration with respect to the broad H2O or D2O solvent response in a 2D spec-
trum. Nevertheless, background subtraction of the buffer response is still critical to reliably
isolate the Aha signal, and a host of experimental and data processing techniques have been
employed in concert to make that possible (see Supporting Information for additional de-
tails). First, a syringe pump sample delivery system together with a flow cell was used to
exchange sample and buffer solutions multiple times with minimal perturbation to the inter-
ferometer. Second, we use the boxcars geometry, which as a background-free method offers
the highest possible sensitivity28, in comparison to the experimentally easier pump-probe
geometry29,30. Third, fast mechanical scanning of the coherence time delays, taking only
≈0.1 s per single scan, effectively reduces the laser noise, which is not δ-correlated but has
a typical correlation time in the order of 1 s.29. Fast scanning is implemented through voice
coil scanning stages, allowing for the acquisition of data at the Nyquist frequency of the
mid-IR field between each successive laser shot (see Fig. S1). Fourth, the deleterious effects
of laser scattering are minimized through the use of quasi phase-shifting of the initial co-
herence time pulses31. Finally, inherent phasing of the heterodyne-detected 2D IR spectra32
is performed using the solvent response as a reference, allowing for precise phasing of each
measurement independently (see Fig. S2). These concerted efforts have led to a lower limit
of sensitivity of ∼100 µM of Aha, a concentration resulting in a linear optical density of
merely ∼100 µOD (in a cuvette with ∼25 µm path length) for the azido stretch vibration33.
We demonstrate here that binding interactions with dissociation constants on the order of
10−5 M and larger become accessible to IR methods with such instrumentation.
To that end, we study the equilibrium binding of two Aha-mutated peptides (i.e.,
Val(-0)Aha and Val(-3)Aha), derived from the Ras-associating guanine nucleotide exchange
factor 2 (RA-GEF), to a PDZ2 domain from the protein tyrosine phosphatase 1E34,35. PDZ2
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FIG. 1: The PDZ2 domain from the human tyrosine phosphatase 1E (PDB ID 3LNY). Left: the
protein consists of six β-strands and two α-helices, with a recognition domain in the groove formed
between α2 and β2. Right: the wild type RA-GEF peptide ligand forms an extended β-sheet
through interaction with β2. Also shown are the two mutation sites considered in this work, the
C-terminal Val(-0) and Val(-3).
domains consist of six β-strands and two α-helices, structured such that a binding groove
spans strand β2 and helix α2 (see Fig. 1), and biomolecular recognition occurs primarily
through interactions with the C-terminus of target proteins36–38 in a 1:1 stoichiometry39.
Assuming that the structure of the bound ligand remains the same upon mutation, the Aha
side chain is expected to be buried in the hydrophobic recognition pocket of the binding
groove in the case of Val(-0)Aha, but points outward in Val(-3)Aha (see Fig. 1). Previous
2D IR experiments support that structural picture25.
To determine the binding affinity directly from the infrared response of the Aha-mutated
ligands, a series of 2D IR experiments were performed, fixing the initial free ligand concentra-
tion (and thus also the Aha concentration) at 500 µM and varying the PDZ2 concentration
(see Fig. 2a,c). 2D IR spectra of uncoupled vibrational modes consist of two peaks of
opposite sign, related to the transition between the ground and first excited state of the
vibrator (0–1 transition, shown in blue in Fig. 2a,c) and the transition between the first and
second excited state (1–2 transition, in red)28. Here, we focus on the 0–1 transition, which
is found along the diagonal of the 2D spectrum, while the 1–2 transition is off-diagonal and
for the most part outside the spectral window shown in Fig. 2a,c. The 0–1 signal along the
diagonal, which has been extracted in Fig. 2b,d, is free from overlapping contributions of
the 1–2 band, allowing for an unambiguous measure of the population of the corresponding
ensemble.
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FIG. 2: Biomolecular recognition observed with 2D IR spectroscopy. (a) Sequence of 2D IR spectra
of Aha in Val(-3)Aha as a function of molar ratio of PDZ2:peptide, as indicated in the top left of
each spectrum. (b) Quantification of the bound and unbound peptide fractions through fitting the
diagonal response to a sum of two Gaussians; in blue for the unbound peptide and in red for the
tightly bound peptide. Panels (c,d) show the same for Val(-0)Aha, for a which a 3rd component
related to an encounter complex is added in green. The vertical lines mark the central frequencies
of the various contributions and are shown to guide the eye.
The results for Val(-3)Aha are shown in Fig. 2a,b. With no PDZ2 domain present
(leftmost panel), we observe a broad peak at ∼2112 cm−1 due to the Aha in the unbound
peptide. With increasing molar ratio of the PDZ2 domain, the band initially broadening
and gradual shifts towards ∼2107 cm−1 due to binding of the ligand to the protein. Binding
is essentially saturated already at a molar ratio of 1.4, with minimal deviations up to a
molar ratio of 5. For a global fitting of the data, we first determined the central frequencies
and widths of two Gaussian distributions of unbound and fully bound ligand, respectively,
from the data at molar ratios 0 (Fig. 2b, leftmost panel) and 5 (Fig. 2b, rightmost panel),
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and subsequently extracted the amplitudes of these two ensembles as a function of protein
concentration. The results of that analysis is shown in Fig. 3a, where the populations are
fit to a two-state binding model:
P + L ⇀↽ PL, (1)
revealing a dissociation constant of KD = 22± 10 µM, which is in excellent agreement with
that obtained from ITC (KD = 33± 5 µM, see Fig. S3a in Supporting Information).
The results for Val(-0)Aha are richer in content (Fig. 2c,d). With no PDZ2 domain
present, the spectrum is essentially the same as for Val(-3)Aha with a center-frequency
of 2112.5 cm−1. With increasing molar ratio of the PDZ2 domain, an additional band is
observed, initially appearing as an elongation of the band to lower frequencies (molar ratio
0.4), and then evolving into a second distinct red-shifted band at ∼2097 cm−1 at molar
ratios 1.6 and beyond. However, the original band doesn’t disappear even at the highest
protein concentration, as one might expect, instead, a careful inspection of the 2D IR spectra
reveals a small frequency red-shift of that peak of about 2.5 cm−1 (see vertical lines in Fig.
2c,d). It has been shown that the Aha frequency reflects the degree of solvation19, hence we
can conclude that the three peaks represent the following conformations: at 2112.5 cm−1,
the unbound and random coiled peptide, where the broad line shape is indicative of a
heterogeneous local solvent environment; at 2110 cm−1, a loosely bound peptide with a
solvated side chain such that the azido group experiences a similarly heterogeneous local
environment as in the unbound case; and at 2097 cm−1, a more tightly bound peptide
with the side chain buried in the hydrophobic recognition pocket, where the lack of solvent
exposure leads to a more homogeneous local environment and thus a narrow line shape.
Recent molecular dynamics simulations of the binding of the wild-type peptide to the
PDZ2 domain38 suggest that the loosely bound peptide is in fact an encounter complex,
in which the ligand is not yet bound inside the binding groove. Rather, stabilized by non-
native salt bridges formed with residues from α2 and β2, the ligand spans across the binding
groove (see Fig. 6 of Ref.38). In such an encounter complex, the Aha label remains solvated
to almost the same extent as in the unbound peptide, leading to the only minor frequency
shift of its vibration. This assignment suggests a model:
P + L ⇀↽ PL1 ⇀↽ PL2, (2)
with a dissociation constant of the encounter complex KD1 ≡ [P ][L]/[PL1] and an equilib-
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rium constant between encounter complex and tightly bound peptide K12 ≡ [PL2]/[PL1].
A fit as for Val(-3)Aha turned out to be under-determined in this case, because of the three
overlapping distributions with a very small frequency shift of unbound peptide vs. encounter
complex and the fact that binding is not completely saturated even at a molar ratio 5.9.
Rather, we included the model Eq. 2 in a single global fitting step of the complete data set,
thereby fixing the relative amplitudes of the three contributions as a function of protein con-
centration to the model (see Supporting Information for details). This procedure rendered
the fit stable and revealed KD1 = 470± 100 µM and K12 = 0.8± 0.2 (Figs. 2d and 3b).
To connect these results to ITC, which cannot distinguish the two binding modes and thus
measures the combined effect of both, we note that model Eq. 2 is mathematically identical
to model Eq. 1 when replacing [PL] ≡ [PL1] + [PL2] and defining an overall dissociation
constant:
KallD ≡
[P ][L]
[PL1] + [PL2]
=
KD1
1 +K12
. (3)
With that, we obtain KallD = 250± 50 µM, again in excellent agreement with the ITC result
of 250± 60 µM (see Fig. S3b in Supporting Information).
It is the C-terminal carboxyl group together with the hydrophobic interactions of the
Val(-0) side chain in the recognition pocket that is mostly responsible for binding36–38. Con-
sequently, mutation of Val(-0) with the longer and weakly polar Aha side chain, which is
still buried in the hydrophobic recognition pocket according to the 2D IR results, destabi-
lizes the tightly bound state, as evidenced by the rather large KallD (250 ± 50 µM). This,
in turn, increases the relative population of the encounter complex so that it becomes ex-
perimentally observable. Val(-3)Aha, on the other hand, has a much larger binding affinity
(KD = 22 ± 10 µM), similar to that of the wild type peptide. Based on the high binding
affinity, we may assume that the structure in the binding groove is the same as the wild type
(Fig. 1), hence, the Aha label points outwards and thus is solvated to a significant extent
even if the ligand is tightly bound. We therefore would not be able to spectroscopically
distinguish the tightly bound peptide from an encounter complex. However, when assuming
that the dissociation constant KD1 of the encounter complex is about the same in both
mutants (since it binds less specifically), we can still conclude from Eq. 3 that the encounter
complex is hardly populated in Val(-3)Aha.
The spectroscopic approach proposed here is similar to NMR5–9 with a “chemical shift”
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FIG. 3: Normalized amplitudes of the various states of (a) Val(-3)Aha and (b) Val(-0)Aha as a
function of molar ratio of PDZ2:peptide. In panel (a), the population of the unbound peptide is
shown in blue and that of the bound peptide in red together with a fit based on the model Eq. 1.
Panel (b) shows in addition the population of the encounter complex in green with a fit based on
the model Eq. 2. The fitting strategies are different in both cases, as discussed in the text and in
Supporting Information.
that reports on the environment of a spectroscopic probe. In the affinity regime of the system
studied here, NMR would be in the limit of coalescing lines40, in which case only one band is
observed, whose frequency position reflects the average over all states. While methods based
on relaxation dispersion have been developed to recover exchange rates and chemical shift of
those “invisible states”40,41, 2D IR is inherently an ultrafast spectroscopy, and coalescence
will not occur for any process slower than ∼1 ps. This is why, in the present study, the
three states of Val(-0)Aha indeed reveal three bands. Both spectroscopic techniques, NMR
and 2D IR, are thus complementary.
While the technical challenges of measuring weak infrared signals have to now limited
the application of IR methods in biomolecular recognition, these measurements pave the
way for greater adoption of unnatural amino acids as infrared probes for protein-protein and
protein-ligand interactions. Different vibrational labels that respond more strongly to the
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environment, such as ester groups in non-natural amino acid side chains21, might be able
to resolve even more binding modes. Furthermore, with recent advances in high repetition
rate amplified laser systems, multidimensional IR spectroscopy of equilibrium biomolecular
recognition will be accessible within seconds42,43, allowing for the collection of a complete
binding interaction curve in a fraction of the time needed for thermodynamic measures
of binding, while simultaneously yielding greater structural information reflecting possible
conformational heterogeneity. These measurements also serve as a proof of principle for the
application of unnatural amino acids to non-equilibrium experiments, in which an actinic
pump pulse initiates a structural process such as ligand unbinding, which is then followed
by transient 2D IR spectroscopy44. Together with similar sensitivity requirements as in the
present case, the observation of such non-equilibrium processes will need the fast intrinsic
time-resolution of 2D IR spectroscopy, the critical feature distinct from established methods
used to determine biomolecular recognition
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